ISO690 Edition Citation

BERNSTEIN, I. L. 1999. Disease management of drug hypersensitivity: a practice parameter: These parameters were developed by the joint task force on practice parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the joint Council of Allergy, Asthma and Immunology. McLean: American College of Allergy, Asthma and Immunology.

APA (7th ed.) Citation

Bernstein, I. L. (1999). Disease management of drug hypersensitivity: a practice parameter: These parameters were developed by the joint task force on practice parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the joint Council of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology.

Chicago Style (17th ed.) Citation

Bernstein, I. Leonard. Disease Management of Drug Hypersensitivity: A Practice Parameter: These Parameters Were Developed by the Joint Task Force on Practice Parameters, Representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. McLean: American College of Allergy, Asthma and Immunology, 1999.

MLA (9th ed.) Citation

Bernstein, I. Leonard. Disease Management of Drug Hypersensitivity: A Practice Parameter: These Parameters Were Developed by the Joint Task Force on Practice Parameters, Representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology, 1999.